Zidan, A.; Alabbad, S.; Ali, T.; Nizami, I.; Haberal, M.; Tokat, Y.; Kamel, R.; Said, H.; Abdelaal, A.; Elsharkawy, M.; El Fouly, A.; Sayed, H.; Al-Mousawi, M.; AlGhonaim, M.; Broering, D. Position Statement of Transplant Activity in the Middle East in Era of COVID-19 Pandemic. Transplantation2020, 104 (11), 2205–2207. https://doi.org/10.1097/TP.0000000000003348.
Jaradat, D.; Bagias, G.; Lorf, T.; Tokat, Y.; Obed, A.; Oezcelik, A. Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: Outcomes and Prognostic Factors for Mortality. A Multicenter Analysis. Clin Transplant2020, e14094. https://doi.org/10.1111/ctr.14094.
Akyildiz, M.; Gungor, G.; Guler, N.; Acar, S.; Erdogan, Y.; Gencdal, G.; Dayangaç, M.; Tokat, Y. Adult Living Donor Liver Transplantation from Donors with Gilbert’s Syndrome: Is It Safe? Clin Transplant2020, 34 (9), e14015. https://doi.org/10.1111/ctr.14015.
Alim, A.; Dayangac, M.; Erdogan, Y.; Malamutmann, E.; Yuzer, Y.; Tokat, Y.; Oezcelik, A. Splenic Artery Transposition for Arterial Reconstruction in Living Donor Liver Transplantation. Transplant Proc2020. https://doi.org/10.1016/j.transproceed.2020.02.155.
Canbolat, İ. P.; Akdeniz, C.; Ferah, O.; Tokat, Y. Post-Operative N-Terminal pro-Brain Natriuretic Peptide Predicts in-Hospital Mortality after Living Donor Liver Transplantation. Turk Kardiyol Dern Ars2020, 48 (4), 374–379. https://doi.org/10.5543/tkda.2020.42637.
Çelebi, F.; Yaghouti, K.; Cindil, E.; Dogusoy, G. B.; Tokat, Y.; Balcı, C. The Role of 18F-FDG PET/MRI in the Assessment of Primary Intrahepatic Neoplasms. Acad Radiol2020. https://doi.org/10.1016/j.acra.2020.01.026.
Çabuk, F.; Başsüllü, N.; Türkmen, İ.; Dayangaç, M.; Akyıldız, M.; Yüzer, Y.; Tokat, Y.; Doğusoy, G. The Prognostic Relationship between Histopathological and Immunohistochemical Features of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma and Mixed Type. Pol J Pathol2020, 71 (2), 79–86. https://doi.org/10.5114/pjp.2020.97015.
Alim, A.; Malamutmann, E.; Dayangac, M.; Erdogan, Y.; Gokakin, A. K.; Tokat, Y.; Oezcelik, A. Comorbidity Index as a Selection Tool for Living Donor Liver Transplantation in Elderly Patients. Transplant Proc2019, 51 (10), 3315–3319. https://doi.org/10.1016/j.transproceed.2019.07.030.
Petrowsky, H.; Kim, K.-H.; Tokat, Y. Editorial: Living-Donor Liver Transplantation: Why the Sun Rises in the East and Sets in the West? Curr Opin Organ Transplant2019, 24 (5), 620–622. https://doi.org/10.1097/MOT.0000000000000700.
Server, S.; Sabet, S.; Sahin, T.; Guven, K.; Aydın, U.; Tokat, Y.; Inan, N. Novel Application of Internal-External Drainage Catheter as Biliary Stent for Percutaneous Transhepatic Treatment of Biliary Strictures in Living Donor Liver Transplantation Recipient Patients. Transplant Proc2019, 51 (7), 2469–2472. https://doi.org/10.1016/j.transproceed.2019.01.153.
Server, S.; Sabet, S.; Bilgin, R.; Inan, N.; Yuzer, Y.; Tokat, Y. Intravoxel Incoherent Motion Parameters for Assessing the Efficiency of Locoregional Bridging Treatments before Liver Transplantation. Transplant Proc2019, 51 (7), 2391–2396. https://doi.org/10.1016/j.transproceed.2019.01.161.
Server, S.; Sabet, S.; Yaghouti, K.; Namal, E.; Inan, N.; Tokat, Y. Value of Imaging Findings in the Prediction of Microvascular Invasion in Hepatocellular Carcinoma. Transplant Proc2019, 51 (7), 2403–2407. https://doi.org/10.1016/j.transproceed.2019.01.178.
Serin, A.; Tokat, Y. Recurrence of Hepatitis D Virus in Liver Transplant Recipients With Hepatitis B and D Virus-Related Chronic Liver Disease. Transplant Proc2019, 51 (7), 2457–2460. https://doi.org/10.1016/j.transproceed.2019.01.163.
Serin, A.; Sahin, T.; Emek, E.; Arikan, T.; Koculu, S.; Yazici, P.; Mammadov, E.; Yuzer, Y.; Tokat, Y. Role of Preoperative Viral Load and Presence of Hepatocellular Carcinoma in the Biliary Complications After Liver Transplantation Due to Hepatitis C Virus. Transplant Proc2019, 51 (7), 2482–2485. https://doi.org/10.1016/j.transproceed.2019.02.043.
Serin, A.; Sahin, T.; Arikan, B. T.; Emek, E.; Bozkurt, B.; Tokat, Y. A Changing Etiologic Scenario in Liver Transplantation: A Single-Center Cohort Study From Turkey. Transplant Proc2019, 51 (7), 2416–2419. https://doi.org/10.1016/j.transproceed.2019.01.190.
Sahin, T.; Serin, A.; Emek, E.; Bozkurt, B.; Arikan, B. T.; Tokat, Y. Effectiveness of Noninvasive Fibrosis Markers for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B and Chronic Hepatitis B+D Induced Cirrhosis. Transplant Proc2019, 51 (7), 2397–2402. https://doi.org/10.1016/j.transproceed.2019.01.193.
Sahin, T.; Arikan, B. T.; Serin, A.; Emek, E.; Bozkurt, B.; Server, S.; Dibekoglu, C.; Tokat, Y. The Utility of Noninvasive Scoring Systems for Prediction of Hepatic Steatosis in Liver Transplantation Donor Candidates. Transplant Proc2019, 51 (7), 2383–2386. https://doi.org/10.1016/j.transproceed.2019.01.177.
Ferah, O.; Akbulut, A.; Açık, M. E.; Gökkaya, Z.; Acar, U.; Yenidünya, Ö.; Yentür, E.; Tokat, Y. Scoring Systems and Postoperative Outcomes in Pediatric Liver Transplantation. Transplant Proc2019, 51 (7), 2430–2433. https://doi.org/10.1016/j.transproceed.2019.01.174.
Ferah, O.; Akbulut, A.; Açik, M. E.; Gökkaya, Z.; Acar, U.; Yenidünya, Ö.; Yentür, E.; Tokat, Y. Acute Kidney Injury After Pediatric Liver Transplantation. Transplant Proc2019, 51 (7), 2486–2491. https://doi.org/10.1016/j.transproceed.2019.01.179.
Emek, E.; Yesim Kara, Z.; Demircan, F. H.; Serin, A.; Yazici, P.; Sahin, T.; Tokat, Y.; Bozkurt, B. Analysis of the Liver Transplant Waiting List in Our Center. Transplant Proc2019, 51 (7), 2413–2415. https://doi.org/10.1016/j.transproceed.2019.01.192.
Emek, E.; Serin, A.; Sahin, T.; Yazici, P.; Yuzer, Y.; Tokat, Y.; Bozkurt, B. Experience in Liver Transplantation Due to Primary Sclerosing Cholangitis: A Single Center Experience. Transplant Proc2019, 51 (7), 2439–2441. https://doi.org/10.1016/j.transproceed.2019.01.156.
Canbolat, I. P.; Adali, G.; Akdeniz, C. S.; Bozkurt, B.; Ferah, O.; Bulutcu, F.; Yuzer, Y.; Tokat, Y. Postoperative Myocardial Injury Does Not Predict Early and 1-Year Mortality After Living Donor Liver Transplantation. Transplant Proc2019, 51 (7), 2478–2481. https://doi.org/10.1016/j.transproceed.2019.02.046.
Bozkurt, B.; Emek, E.; Arikan, T.; Ceyhan, O.; Yazici, P.; Sahin, T.; Mammadov, E.; Serin, A.; Gurcan, N. I.; Yuzer, Y.; Tokat, Y. Liver Graft Volume Estimation by Manual Volumetry and Software-Aided Interactive Volumetry: Which Is Better? Transplant Proc2019, 51 (7), 2387–2390. https://doi.org/10.1016/j.transproceed.2019.01.152.
Arikan, T.; Emek, E.; Bozkurt, B.; Mammadov, E.; Ceyhan, O.; Sahin, T.; Dibekoglu, C.; Serin, A.; Aydin, U.; Tokat, Y. Does Multiple Bile Duct Anastomosis in Living Donor Liver Transplantation Affect the Postoperative Biliary Complications? Transplant Proc2019, 51 (7), 2473–2477. https://doi.org/10.1016/j.transproceed.2019.01.160.
Adalı, G.; Bozkurt, B.; Ceyhan, Ö.; Server, S.; Doğusoy, G. B.; Yüzer, Y.; Tokat, Y. Body Mass Index and Unenhanced CT as a Predictor of Hepatic Steatosis in Potential Liver Donors. Transplant Proc2019, 51 (7), 2373–2378. https://doi.org/10.1016/j.transproceed.2019.02.047.
Acar, U.; Gökkaya, Z.; Akbulut, A.; Ferah, O.; Yenidünya, Ö.; Açık, M. E.; Tokat, Y.; Yentür, E. Impact of Cytokine Adsorption Treatment in Liver Failure. Transplant Proc2019, 51 (7), 2420–2424. https://doi.org/10.1016/j.transproceed.2019.01.167.
Sokmen, B. K.; Sabet, S.; Oz, A.; Server, S.; Namal, E.; Dayangac, M.; Dogusoy, G. B.; Tokat, Y.; Inan, N. Value of Intravoxel Incoherent Motion for Hepatocellular Carcinoma Grading. Transplant Proc2019, 51 (6), 1861–1866. https://doi.org/10.1016/j.transproceed.2019.02.027.
Haldar, D.; Kern, B.; Hodson, J.; Armstrong, M. J.; Adam, R.; Berlakovich, G.; Fritz, J.; Feurstein, B.; Popp, W.; Karam, V.; Muiesan, P.; O’Grady, J.; Jamieson, N.; Wigmore, S. J.; Pirenne, J.; Malek-Hosseini, S. A.; Hidalgo, E.; Tokat, Y. et al. Outcomes of Liver Transplantation for Non-Alcoholic Steatohepatitis: A European Liver Transplant Registry Study. J Hepatol2019, 71 (2), 313–322. https://doi.org/10.1016/j.jhep.2019.04.011.
Suner, A.; Carr, B. I.; Akkiz, H.; Uskudar, O.; Kuran, S.; Tokat, Y.; Tokmak, S.; Ballı, T.; Ulku, A et al. Inflammatory Markers C-Reactive Protein and PLR in Relation to HCC Characteristics. J Transl Sci2019, 5 (3). https://doi.org/10.15761/JTS.1000260.
Tsochatzis, E.; Coilly, A.; Nadalin, S.; Levistky, J.; Tokat, Y.; Ghobrial, M.; Klinck, J.; Berenguer, M. International Liver Transplantation Consensus Statement on End-Stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation. Transplantation2019, 103 (1), 45–56. https://doi.org/10.1097/TP.0000000000002433.
Suner, A.; Carr, B. I.; Akkiz, H.; Karakülah, G.; Üsküdar, O.; Yalçın, K.; Kuran, S.; Tokat, Y. et al. C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular Carcinoma. Oncology2019, 96 (1), 25–32. https://doi.org/10.1159/000492473.
Alim, A.; Erdogan, Y.; Dayangac, M.; Yuzer, Y.; Tokat, Y.; Oezcelik, A. Normal Primary Graft Function Despite Early Hepatic Artery Thrombosis After Living-Donor Liver Transplant. Exp Clin Transplant2018. https://doi.org/10.6002/ect.2017.0363.
Öz, A.; Koyuncu Sökmen, B.; İnan, N.; Balcı, N. C.; Tokat, Y. Incidentally Detected PET-Avid Liver Adenomatosis: MRI and 18F-FDG PET-CT Findings. Turk J Gastroenterol2018, 29 (5), 623–624. https://doi.org/10.5152/tjg.2018.18105.
Aumann, E. K.; Server, S.; Koyuncu Sokmen, B.; Oz, A.; Namal, E.; Gurcan, N. I.; Balci, N. C.; Tokat, Y. Diagnostic Performances of Intravoxel Incoherent Motion and Conventional Diffusion-Weighted Imaging in the Differential Diagnosis of Benign and Malignant Portal Vein Thrombus. Abdom Radiol (NY)2018, 43 (9), 2270–2276. https://doi.org/10.1007/s00261-018-1467-6.
Carr, B. I.; Akkiz, H.; Üsküdar, O.; Yalçın, K.; Guerra, V.; Kuran, S.; Karaoğullarından, Ü.; Altıntaş, E.; Özakyol, A.; Tokmak, S.; Ballı, T.; Yücesoy, M.; Bahçeci, H. İ.; Ülkü, A.; Akçam, T.; Polat, K. Y.; Ekinci, N.; Şimşek, H.; Örmeci, N.; Sonsuz, A.; Demir, M.; Kılıç, M.; Uygun, A.; Demir, A.; Delik, A.; Arslan, B.; Doran, F.; Yilmaz, S.; Tokat, Y. HCC with Low- and Normal-Serum Alpha-Fetoprotein Levels. Clin Pract (Lond)2018, 15 (1), 453–464. https://doi.org/10.4172/clinical-practice.1000393.
Carr, B. I.; Akkiz, H.; Guerra, V.; Üsküdar, O.; Kuran, S.; Karaoğullarından, Ü.; Tokmak, S.; Ballı, T.; Ülkü, A.; Akçam, T.; Delik, A.; Arslan, B.; Doran, F.; Yalçın, K.; Altntaş, E.; Özakyol, A.; Yücesoy, M.; Bahçeci, H. İ.; Polat, K. Y.; Ekinci, N.; Şimşek, H.; Örmeci, N.; Sonsuz, A.; Demir, M.; Kılıç, M.; Uygun, A.; Demir, A.; Yilmaz, S.; Tokat, Y. C-Reactive Protein and Hepatocellular Carcinoma: Analysis of Its Relationships to Tumor Factors. Clin Pract (Lond)2018, 15 (Spec Issue), 625–634. https://doi.org/10.4172/clinical-practice.1000409.
Canbolat, I. P.; Erdogan, Y.; Adali, G.; Kaplan, O.; Dayangac, M.; Yuzer, Y.; Tokat, Y. The Predictive Value of Risk Indices for Cardiac Complications in Living Donor Liver Transplantation. Bratisl Lek Listy2018, 119 (5), 289–293. https://doi.org/10.4149/BLL_2018_054.
Akkiz, H.; Carr, B. I.; Kuran, S.; Karaoğullarından, Ü.; Üsküdar, O.; Tokmak, S.; Arslan, B.; Doran, F.; Balli, H. T.; Ülkü, A.; Akçam, T. A.; Bahçeci, H. İ.; Polat, K. Y.; Örmeci, N.; Şimşek, H.; Sonsuz, A.; Demir, A.; Altıntaş, E.; Demir, M.; Yalçın, K.; Ekinci, N.; Harmancı Özakyol, A.; Yücesoy, M.; Uygun, A.; Guerra, V.; Delik, A.; Tokat, Y.; Yilmaz, S.; Bektaş, A.; Kılıç, M. Macroscopic Portal Vein Thrombosis in HCC Patients. Can J Gastroenterol Hepatol2018, 2018, 3120185. https://doi.org/10.1155/2018/3120185.
Acar, Ş.; Güngör, G.; Dayangaç, M.; Diz-Küçükkaya, R.; Tokat, Y.; Akyıldız, M. Liver Transplantation in a Patient with Acquired Dysfibrinogenemia Who Presented with Subdural Hematoma: A Case Report. Turk J Haematol2017, 34 (4), 356–357. https://doi.org/10.4274/tjh.2017.0045.
Alim, A.; Tokat, Y.; Erdogan, Y.; Gokkaya, Z.; Dayangac, M.; Yuzer, Y.; Oezcelik, A. Liver Transplantation for Homozygote Familial Hypercholesterolemia: The Only Curative Treatment. Pediatr Transplant2016, 20 (8), 1060–1064. https://doi.org/10.1111/petr.12763.
Alim, A.; Erdogan, Y.; Yuzer, Y.; Tokat, Y.; Oezcelik, A. Graft-to-Recipient Weight Ratio Threshold Adjusted to the Model for End-Stage Liver Disease Score for Living Donor Liver Transplantation. Liver Transpl2016, 22 (12), 1643–1648. https://doi.org/10.1002/lt.24523.
Idilman, R.; Akyildiz, M.; Keskin, O.; Gungor, G.; Yilmaz, T. U.; Kalkan, C.; Dayangac, M.; Cinar, K.; Balci, D.; Hazinedaroglu, S.; Tokat, Y. The Long-Term Efficacy of Combining Nucleos(t)Ide Analog and Low-Dose Hepatitis B Immunoglobulin on Post-Transplant Hepatitis B Virus Recurrence. Clin Transplant2016, 30 (10), 1216–1221. https://doi.org/10.1111/ctr.12804.
Dayangac, M.; Tokat, Y. The Evolution of Anterior Sector Venous Drainage in Right Lobe Living Donor Liver Transplantation: Does One Technique Fit All? Hepatobiliary Surg Nutr2016, 5 (2), 151–158. https://doi.org/10.3978/j.issn.2304-3881.2015.08.01.
Gunay, Y.; Guler, N.; Yaprak, O.; Dayangac, M.; Akyildiz, M.; Altaca, G.; Yuzer, Y.; Tokat, Y. Living Donor Liver Transplantation Outcomes for Hepatocellular Carcinoma Beyond Milan or UCSF Criteria. Indian J Surg2015, 77 (Suppl 3), 950–956. https://doi.org/10.1007/s12262-014-1078-6.
Arat, N.; Akyıldız, M.; Tellioğlu, G.; Tokat, Y. Authors’ Reply. Turk Kardiyol Dern Ars2015, 43 (6), 586–587. https://doi.org/10.5543/tkda.2015.
Oezcelik, A.; Dayangac, M.; Guler, N.; Yaprak, O.; Erdogan, Y.; Akyildiz, M.; Sevdik, Z.; Yuzer, Y.; Tokat, Y. Living Donor Liver Transplantation in Patients 70 Years or Older. Transplantation2015, 99 (7), 1436–1440. https://doi.org/10.1097/TP.0000000000000524.
Guler, N.; Yaprak, O.; Gunay, Y.; Dayangac, M.; Akyildiz, M.; Yuzer, F.; Yuzer, Y.; Tokat, Y. Major Complications of Adult Right Lobe Living Liver Donors. Hepatobiliary Pancreat Dis Int2015, 14 (2), 150–156. https://doi.org/10.1016/s1499-3872(15)60346-0.
Arat, N.; Akyıldız, M.; Tellioğlu, G.; Tokat, Y. Cardiac Involvement of Primary Hyperoxaluria Accompanied by Non-Compaction Cardiomyopathy and Patent Ductus Arteriosus. Turk Kardiyol Dern Ars2015, 43 (3), 288–291. https://doi.org/10.5543/tkda.2015.46026.
Demirbas, T.; Akyildiz, M.; Dayangac, M.; Yaprak, O.; Dogusoy, G.; Bassullu, N.; Yuzer, Y.; Tokat, Y. Living Donor Right Lobe Liver Transplantation as a Treatment for Hepatic Alveolar Echinococcosis: Report of Three Cases. Hepatogastroenterology2015, 62 (137), 93–97.
Gunay, Y.; Guler, N.; Dayangac, M.; Taskesen, F.; Yaprak, O.; Emek, E.; Akyildiz, M.; Altaca, G.; Yuzer, Y.; Tokat, Y. Living Donor Liver Transplantation for Obese Patients: Challenges and Outcomes. Liver Transpl2014, 20 (3), 311–322. https://doi.org/10.1002/lt.23794.
Gunay, Y.; Guler, N.; Akyildiz, M.; Yaprak, O.; Dayangac, M.; Yuzer, Y.; Tokat, Y. Management of Patients with Recurrent Hepatocellular Carcinoma Following Living Donor Liver Transplantation: A Single Center Experience. Gulf J Oncolog2014, 1 (15), 12–18.
Guler, N.; Unalp, O.; Guler, A.; Yaprak, O.; Dayangac, M.; Sozbilen, M.; Akyildiz, M.; Tokat, Y. Glasgow Coma Scale and APACHE-II Scores Affect the Liver Transplantation Outcomes in Patients with Acute Liver Failure. Hepatobiliary Pancreat Dis Int2013, 12 (6), 589–593. https://doi.org/10.1016/s1499-3872-13-60093-4.
Guler, N.; Dayangac, M.; Yaprak, O.; Akyildiz, M.; Gunay, Y.; Taskesen, F.; Tabandeh, B.; Bulutcu, F.; Yuzer, Y.; Tokat, Y. Anatomical Variations of Donor Portal Vein in Right Lobe Living Donor Liver Transplantation: The Safe Use of Variant Portal Veins. Transpl Int2013, 26 (12), 1191–1197. https://doi.org/10.1111/tri.12190.
Guler, N.; Gunay, Y.; Dayangac, M.; Yaprak, O.; Akyildiz, M.; Yuzer, Y.; Tokat, Y. Liver Transplantation for Fulminant Hepatic Failure Due to Iatrogenic Porta Hepatis Injury. Minerva Chir2013, 68 (3), 333–334.
Demirbas, T.; Bulutcu, F.; Dayangac, M.; Yaprak, O.; Guler, N.; Oklu, L.; Akyildiz, M.; Altaca, G.; Tokat, Y.; Yuzer, Y. Which Incision Is Better for Living-Donor Right Hepatectomy? Midline, J-Shaped, or Mercedes. Transplant Proc2013, 45 (1), 218–221. https://doi.org/10.1016/j.transproceed.2012.06.081.
Demirbas, B. T.; Piskin, T.; Dayangac, M.; Yaprak, O.; Oklu, L.; Yuzer, Y.; Tokat, Y. Successful Treatment of Severe Hepatorenal Syndrome with Living Donor Liver Transplantation. Hepatogastroenterology2012, 59 (119), 2305–2306. https://doi.org/10.5754/hge10791.
Bassullu, N.; Turkmen, I.; Dayangac, M.; Yagiz Korkmaz, P.; Yasar, R.; Akyildiz, M.; Yaprak, O.; Tokat, Y.; Yuzer, Y.; Bulbul Dogusoy, G. The Predictive and Prognostic Significance of C-Erb-B2, EGFR, PTEN, MTOR, PI3K, P27, and ERCC1 Expression in Hepatocellular Carcinoma. Hepat Mon2012, 12 (10 HCC), e7492. https://doi.org/10.5812/hepatmon.7492.
Yaprak, O.; Guler, N.; Balci, N. C.; Dayangac, M.; Demirbas, T.; Killi, R.; Tokat, Y.; Yuzer, Y. A New Technique for the Reconstruction of Complex Portal Vein Anomalies in Right Lobe Living Liver Donors. Hepatobiliary Pancreat Dis Int2012, 11 (4), 438–441. https://doi.org/10.1016/s1499-3872-12-60205-7.
Yaprak, O.; Guler, N.; Altaca, G.; Dayangac, M.; Demirbas, T.; Akyildiz, M.; Ulusoy, L.; Tokat, Y.; Yuzer, Y. Ratio of Remnant to Total Liver Volume or Remnant to Body Weight: Which One Is More Predictive on Donor Outcomes? HPB (Oxford)2012, 14 (7), 476–482. https://doi.org/10.1111/j.1477-2574.2012.00483.x.
Yaprak, O.; Akyildiz, M.; Dayangac, M.; Demirbas, B. T.; Guler, N.; Dogusoy, G. B.; Yuzer, Y.; Tokat, Y. AFP Level and Histologic Differentiation Predict the Survival of Patients with Liver Transplantation for Hepatocellular Carcinoma. Hepatobiliary Pancreat Dis Int2012, 11 (3), 256–261. https://doi.org/10.1016/s1499-3872-12-60157-x.
Piskin, T.; Demirbas, T.; Yalcin, L.; Yaprak, O.; Dayangac, M.; Guler, N.; Bulutcu, F.; Yuzer, Y.; Tokat, Y. Recipient Splenic Artery Utilization for Arterial Re-Anastomosis in Living Donor Liver Transplantation: Single-Center Experience. Hepatogastroenterology2012, 59 (116), 1263–1264. https://doi.org/10.5754/hge11642.
Akun, E.; Yaprak, O.; Killi, R.; Balci, N. C.; Tokat, Y.; Yuzer, Y. Vascular Complications in Hepatic Transplantation: Single-Center Experience in 14 Years. Transplant Proc2012, 44 (5), 1368–1372. https://doi.org/10.1016/j.transproceed.2012.02.027.
Bas, K.; Yaprak, O.; Dayangac, M.; Ulusoy, O. L.; Dogusoy, G. B.; Yuzer, Y.; Tokat, Y. Living-Donor Liver Transplant in 3 Patients with Budd-Chiari Syndrome: Case Report. Exp Clin Transplant2012, 10 (2), 172–175. https://doi.org/10.6002/ect.2011.0044.
Demirbas, T.; Piskin, T.; Dayangac, M.; Yaprak, O.; Akyildiz, M.; Tokat, Y.; Yuzer, Y. Right-Lobe Liver Transplant from Donors with Gilbert Syndrome. Exp Clin Transplant2012, 10 (1), 39–42. https://doi.org/10.6002/ect.2011.0063.
Yaprak, O.; Dayangac, M.; Akyildiz, M.; Demirbas, T.; Guler, N.; Bulutcu, F.; Bassullu, N.; Akun, E.; Yuzer, Y.; Tokat, Y. Biliary Complications after Right Lobe Living Donor Liver Transplantation: A Single-Centre Experience. HPB (Oxford)2012, 14 (1), 49–53. https://doi.org/10.1111/j.1477-2574.2011.00401.x.
Bas, K.; Dayangac, M.; Yaprak, O.; Yuzer, Y.; Tokat, Y. International Collaboration of Turkey in Liver Transplantation Research: A Bibliometric Analysis. Transplant Proc2011, 43 (10), 3796–3801. https://doi.org/10.1016/j.transproceed.2011.09.081.
Balci, D.; Dayangac, M.; Yaprak, O.; Akin, B.; Duran, C.; Killi, R.; Yuzer, Y.; Tokat, Y. Living Donor Liver Transplantation for Hepatocellular Carcinoma: A Single Center Analysis of Outcomes and Impact of Different Selection Criteria. Transpl Int2011, 24 (11), 1075–1083. https://doi.org/10.1111/j.1432-2277.2011.01311.x.
Yaprak, O.; Demirbas, T.; Duran, C.; Dayangac, M.; Akyildiz, M.; Tokat, Y.; Yuzer, Y. Living Donor Liver Hilar Variations: Surgical Approaches and Implications. Hepatobiliary Pancreat Dis Int2011, 10 (5), 474–479. https://doi.org/10.1016/s1499-3872-11-60081-7.
Yaprak, O.; Balci, N. C.; Dayangac, M.; Demirbas, T.; Guler, N.; Ulusoy, L.; Tokat, Y.; Yuzer, Y. Cryopreserved Aortic Quilt Plasty for One-Step Reconstruction of Multiple Hepatic Venous Drainage in Right Lobe Living Donor Liver Transplantation. Transplant Proc2011, 43 (7), 2817–2819. https://doi.org/10.1016/j.transproceed.2011.06.064.
Dayangac, M.; Taner, C. B.; Yaprak, O.; Demirbas, T.; Balci, D.; Duran, C.; Yuzer, Y.; Tokat, Y. Utilization of Elderly Donors in Living Donor Liver Transplantation: When More Is Less? Liver Transpl2011, 17 (5), 548–555. https://doi.org/10.1002/lt.22276.
Yaprak, O.; Dayangac, M.; Demirbas, B. T.; Tabendeh, B.; Yuzer, Y.; Tokat, Y. Analysis of Right Lobe Living-Liver Donor Complications: A Single Center Experience. Exp Clin Transplant2011, 9 (1), 56–59.
Umut Ozcan, M.; Ocal, S.; Basdogan, C.; Dogusoy, G.; Tokat, Y. Characterization of Frequency-Dependent Material Properties of Human Liver and Its Pathologies Using an Impact Hammer. Med Image Anal2011, 15 (1), 45–52. https://doi.org/10.1016/j.media.2010.06.010.
Başsüllü, N.; Türkmen, I.; Yaprak, O.; Dayangaç, M.; Demırbaş, T.; Güler, N.; Uraz, S.; Akyildiz, M.; Cığercıoğullari, E.; Tokat, Y.; Yüzer, Y.; Doğusoy, G. B. General Evaluation of Hepatectomy and Hepatocellular Carcinoma Cases. Turk Patoloji Derg2011, 27 (3), 221–229. https://doi.org/10.5146/tjpath.2011.01079.
Dayangac, M.; Taner, C. B.; Akin, B.; Uraz, S.; Balci, D.; Duran, C.; Ayanoglu, O.; Killi, R.; Yuzer, Y.; Tokat, Y. Dual Left Lobe Living Donor Liver Transplantation Using Donors Unacceptable for Right Lobe Donation: A Case Report. Transplant Proc2010, 42 (10), 4560–4563. https://doi.org/10.1016/j.transproceed.2010.09.149.
Yaprak, O.; Dayangac, M.; Balci, D.; Demirbas, T.; Yuzer, Y.; Tokat, Y. Use of Livers from Hepatitis B Core Antibody Positive Donors in Living Donor Liver Transplantation. Hepatogastroenterology2010, 57 (102–103), 1268–1271.
Yaprak, O.; Dayangac, M.; Balci, D.; Bas, K.; Yuzer, Y.; Tokat, Y. Hepatitis B Prophylaxis in Living Donor Liver Transplantation: Single Center Experience. Hepatogastroenterology2010, 57 (102–103), 1178–1182.
Dayangac, M.; Taner, C. B.; Balci, D.; Memi, I.; Yaprak, O.; Akin, B.; Duran, C.; Killi, R.; Ayanoglu, O.; Yuzer, Y.; Tokat, Y. Use of Middle Hepatic Vein in Right Lobe Living Donor Liver Transplantation. Transpl Int2010, 23 (3), 285–291. https://doi.org/10.1111/j.1432-2277.2009.00978.x.
Duran, C.; Uraz, S.; Kantarci, M.; Ozturk, E.; Doganay, S.; Dayangac, M.; Bozkurt, M.; Yuzer, Y.; Tokat, Y. Hepatic Arterial Mapping by Multidetector Computed Tomographic Angiography in Living Donor Liver Transplantation. J Comput Assist Tomogr2009, 33 (4), 618–625. https://doi.org/10.1097/RCT.0b013e31818d814b.
Taner, C. B.; Dayangac, M.; Akin, B.; Balci, D.; Uraz, S.; Duran, C.; Killi, R.; Ayanoglu, O.; Yuzer, Y.; Tokat, Y. Donor Safety and Remnant Liver Volume in Living Donor Liver Transplantation. Liver Transpl2008, 14 (8), 1174–1179. https://doi.org/10.1002/lt.21562.
Balci, D.; Taner, B.; Dayangac, M.; Akin, B.; Yaprak, O.; Duran, C.; Uraz, S.; Hayzaran, S.; Ayanoglu, O.; Killi, R.; Senturk, H.; Yuzer, Y.; Tokat, Y. Splenic Abscess after Splenic Artery Ligation in Living Donor Liver Transplantation: A Case Report. Transplant Proc2008, 40 (5), 1786–1788. https://doi.org/10.1016/j.transproceed.2007.10.012.
Sirvanci, M.; Duran, C.; Ozturk, E.; Balci, D.; Dayangaç, M.; Onat, L.; Yüzer, Y.; Tokat, Y.; Killi, R. The Value of Magnetic Resonance Cholangiography in the Preoperative Assessment of Living Liver Donors. Clin Imaging2007, 31 (6), 401–405. https://doi.org/10.1016/j.clinimag.2007.05.003.
Duran, C.; Taner, B.; Dayangac, M.; Akin, B.; Balci, D.; Kurt, Z.; Killi, R.; Yuzer, Y.; Tokat, Y. Why We Did Not Use This Donor. Liver Transpl2007, 13 (8), 1199–1200. https://doi.org/10.1002/lt.21140.
Uraz, S.; Duran, C.; Balci, D.; Akin, B.; Dayangac, M.; Kurt, Z.; Ayanoglu, O. H.; Killi, R.; Yuzer, Y.; Tokat, Y. A Very Rare Venous Anomaly in a Living Liver Donor: Left Hepatic Venous Connection to the Right Atrium. Transplant Proc2007, 39 (5), 1714–1715. https://doi.org/10.1016/j.transproceed.2006.11.009.
Celebi Kobak, A.; Karasu, Z.; Kilic, M.; Ozacar, T.; Tekin, F.; Gunsar, F.; Ersoz, G.; Yuzer, Y.; Tokat, Y. Living Donor Liver Transplantation from Hepatitis B Core Antibody Positive Donors. Transplant Proc2007, 39 (5), 1488–1490. https://doi.org/10.1016/j.transproceed.2006.11.015.
Karasu, Z.; Akyildiz, M.; Zeytunlu, M.; Noyan, A.; Yuzer, Y.; Tokat, Y.; Kilic, M. Urgent Adult-to-Adult Right Lobe Living Donor Liver Transplantation for Acute Liver Failure; a Single Center Experience from Turkey. Hepatogastroenterology2007, 54 (75), 810–813.
Duran, C.; Aydinli, B.; Tokat, Y.; Yuzer, Y.; Kantarci, M.; Akgun, M.; Polat, K. Y.; Unal, B.; Killi, R.; Atamanalp, S. S. Stereological Evaluation of Liver Volume in Living Donor Liver Transplantation Using MDCT via the Cavalieri Method. Liver Transpl2007, 13 (5), 693–698. https://doi.org/10.1002/lt.21132.
Colak, Y.; Karasu, Z.; Oruc, N.; Can, C.; Balým, Z.; Akarca, U.; Gunsar, F.; Ersoz, G.; Tokat, Y.; Batur, Y. Hyperhomocysteinaemia and Factor V Leiden Mutation Are Associated with Budd-Chiari Syndrome. Eur J Gastroenterol Hepatol2006, 18 (8), 917–920. https://doi.org/10.1097/00042737-200608000-00019.
Atamaz, F.; Hepguler, S.; Karasu, Z.; Kilic, M.; Tokat, Y. The Prevention of Bone Fractures after Liver Transplantation: Experience with Alendronate Treatment. Transplant Proc2006, 38 (5), 1448–1452. https://doi.org/10.1016/j.transproceed.2006.02.074.
Oruc, N.; Tokat, Y.; Killi, R.; Tombuloglu, M.; Ilter, T. Budd-Chiari Syndrome in an Afibrinogenemic Patient: A Paradoxical Complication. Dig Dis Sci2006, 51 (2), 378–380. https://doi.org/10.1007/s10620-006-3141-z.
Arikan, C.; Kilic, M.; Nart, D.; Ozgenc, F.; Ozkan, T.; Tokat, Y.; Yagci, R. V.; Aydogdu, S. Hepatocellular Carcinoma in Children and Effect of Living-Donor Liver Transplantation on Outcome. Pediatr Transplant2006, 10 (1), 42–47. https://doi.org/10.1111/j.1399-3046.2005.00395.x.
Aydogdu, S.; Arikan, C.; Kilic, M.; Ozgenc, F.; Akman, S.; Unal, F.; Yagci, R. V.; Tokat, Y. Outcome of Pediatric Liver Transplant Recipients in Turkey: Single Center Experience. Pediatr Transplant2005, 9 (6), 723–728. https://doi.org/10.1111/j.1399-3046.2005.00366.x.
Ilkgul, O.; Kilic, M.; Içöz, G.; Zeytunlu, M.; Demirpolat, G.; Akyildiz, M.; Tokat, Y.; Parildar, M.; Memis, A. Experience with Mesocaval Shunt with Autologous Jugular Vein Interposition in Patients with Budd-Chiari Syndrome. Hepatogastroenterology2005, 52 (63), 662–665.
Akay, S.; Karasu, Z.; Akyildiz, M.; Tokat, Y.; Goker, E. Successful Treatment of Liver Transplant-Associated Kaposi’s Sarcoma with Long-Term Vincristine. Transplant Proc2005, 37 (5), 2188–2189. https://doi.org/10.1016/j.transproceed.2005.03.024.
Karasu, Z.; Ozacar, T.; Akarca, U.; Ersoz, G.; Erensoy, S.; Gunsar, F.; Kobat, A.; Tokat, Y.; Batur, Y. HBV Vaccination in Liver Transplant Recipients: Not an Effective Strategy in the Prophylaxis of HBV Recurrence. J Viral Hepat2005, 12 (2), 212–215. https://doi.org/10.1111/j.1365-2893.2005.00585.x.
Inceboz, T.; Korkmaz, M.; Tokat, Y.; Uner, A. The First Report of Echinococcus Multilocularis Strain Isolation from Human in Turkey. Turkiye Parazitol Derg2005, 29 (1), 31–33.
Idilman, R.; Erden, E.; Kuzu, I.; Ersoz, S.; Karasu, Z.; Karayalcin, K.; Yuce, G.; Tokat, Y.; Sahin, Y.; Tukun, A.; Akarca, U. S.; Karayalcin, S. Recipient-Derived Hepatocytes in Sex-Mismatched Liver Allografts after Liver Transplantation: Early versus Late Transplant Biopsies. Transplantation2004, 78 (11), 1647–1652. https://doi.org/10.1097/01.tp.0000144055.78462.4f.
Karasu, Z.; Ozacar, T.; Akyildiz, M.; Demirbas, T.; Arikan, C.; Kobat, A.; Akarca, U.; Ersoz, G.; Gunsar, F.; Batur, Y.; Kilic, M.; Tokat, Y. Low-Dose Hepatitis B Immune Globulin and Higher-Dose Lamivudine Combination to Prevent Hepatitis B Virus Recurrence after Liver Transplantation. Antivir Ther2004, 9 (6), 921–927.
Arikan, C.; Ozgenc, F.; Akman, S. A.; Kilic, M.; Tokat, Y.; Yagci, R. V.; Aydogdu, S. Impact of Liver Transplantation on Renal Function of Patients with Congenital Hepatic Fibrosis Associated with Autosomal Recessive Polycystic Kidney Disease. Pediatr Transplant2004, 8 (6), 558–560. https://doi.org/10.1111/j.1399-3046.2004.00224.x.
Orguc, S.; Tercan, M.; Bozoklar, A.; Akyildiz, M.; Gurgan, U.; Celebi, A.; Nart, D.; Karasu, Z.; Icoz, G.; Zeytunlu, M.; Yuzer, Y.; Tokat, Y.; Kilic, M. Variations of Hepatic Veins: Helical Computerized Tomography Experience in 100 Consecutive Living Liver Donors with Emphasis on Right Lobe. Transplant Proc2004, 36 (9), 2727–2732. https://doi.org/10.1016/j.transproceed.2004.10.006.
Karasu, Z.; Ulukaya, S.; Ayanoglu, H. O.; Basturk, B.; Ulukaya, E.; Akyildiz, M.; Tokat, Y. Cytokine Gene Polymorphism and Early Graft Rejection in Liver Transplant Recipients. Transplant Proc2004, 36 (9), 2791–2795. https://doi.org/10.1016/j.transproceed.2004.10.034.
Akay, S.; Karasu, Z.; Akyildiz, M.; Tokat, Y. Adefovir Treatment in Posttransplant Hepatitis B Virus Infection Resistant to Lamivudine plus Hepatitis B Virus Immunoglobulin. Transplant Proc2004, 36 (9), 2768–2770. https://doi.org/10.1016/j.transproceed.2004.09.062.
Ilkgül, O.; Içöz, G.; Dayangaç, M.; Tokat, Y.; Ozütemiz, O. A Case of Antiphospholipid Antibody Syndrome with Budd-Chiari and Colonic Ulcers Complicated with Gastrointestinal Hemorrhage. Turk J Gastroenterol2004, 15 (2), 115–116.
Akyildiz, M.; Karasu, Z.; Cagirgan, S.; Kilic, M.; Tokat, Y. Rituximab Therapy for Life-Threatining Immune Hemolytic Anemia in a Liver Tranplant Recipient: A Case Report. Transplant Proc2004, 36 (5), 1492–1493. https://doi.org/10.1016/j.transproceed.2004.05.042.
Akyildiz, M.; Karasu, Z.; Arikan, C.; Kilic, M.; Zeytunlu, M.; Gunsar, F.; Ersoz, G.; Akarca, U.; Batur, Y.; Tokat, Y. Impact of Pretransplant MELD Score on Posttransplant Outcome in Living Donor Liver Transplantation. Transplant Proc2004, 36 (5), 1442–1444. https://doi.org/10.1016/j.transproceed.2004.05.004.
Ozgenç, F.; Aydoğdu, S.; Aksoylar, S.; Elmas, N.; Yüce, G.; Yağci, R. V.; Tokat, Y. Regenerative Nodule Mimicking Hepatocellular Carcinoma in a Cirrhotic Child Due to Hepatitis B: An Imaging Dilemma. Pediatr Transplant2004, 8 (2), 198–200. https://doi.org/10.1046/j.1399-3046.2003.00019.x.
Kara, E.; Gökhan, I.; Dayangaç, M.; Ilkgül, O.; Ertan, H.; Tokat, Y.; Terzioglu, E. Effect of Portal Venous Injection of Donor Spleen Cells on Skin Allograft Survival in Rat. Indian J Med Res2004, 119 (3), 110–114.
Nart, D.; Arikan, C.; Akyildiz, M.; Yuce, G.; Demirpolat, G.; Zeytunlu, M.; Karasu, Z.; Aydogdu, S.; Killi, R.; Yuzer, Y.; Tokat, Y.; Kilic, M. Hepatocellular Carcinoma in Liver Transplant Era: A Clinicopathologic Analysis. Transplant Proc2003, 35 (8), 2986–2990. https://doi.org/10.1016/j.transproceed.2003.10.076.
Karasu, Z.; Nart, D.; Lebe, E.; Demirbas, T.; Memis, A.; Kilic, M.; Akyildiz, M.; Tokat, Y. Liver Transplantation in a Patient with Budd-Chiari Syndrome Secondary to Factor V Leiden Mutation. Transplant Proc2003, 35 (8), 3008–3010. https://doi.org/10.1016/j.transproceed.2003.10.038.
Aydoğdu, S.; Ozgenç, F.; Yurtsever, S.; Akman, S. A.; Tokat, Y.; Yağci, R. V. Our Experience with Fulminant Hepatic Failure in Turkish Children: Etiology and Outcome. J Trop Pediatr2003, 49 (6), 367–370. https://doi.org/10.1093/tropej/49.6.367.
Ayanoglu, H. O.; Ulukaya, S.; Yuzer, Y.; Tokat, Y. Anesthetic Management and Complications in Living Donor Hepatectomy. Transplant Proc2003, 35 (8), 2970–2973. https://doi.org/10.1016/j.transproceed.2003.10.090.
Arikan, C.; Tekgul, H.; Eğilmez, S.; Kilic, M.; Yagci, R. V.; Tokat, Y.; Aydogdu, S. Stage IV Hepatic Encephalopathy Associated with Acute Blindness after Liver Transplantation. Pediatr Transplant2003, 7 (6), 497–500. https://doi.org/10.1046/j.1397-3142.2003.00118.x.
Arikan, C.; Kilic, M.; Tokat, Y.; Aydogdu, S. Allergic Disease after Pediatric Liver Transplantation with Systemic Tacrolimus and Cyclosporine a Therapy. Transplant Proc2003, 35 (8), 3039–3041. https://doi.org/10.1016/j.transproceed.2003.10.033.
Ulukaya, S.; Arikan, C.; Aydogdu, S.; Ayanoglu, H. O.; Tokat, Y. Immediate Tracheal Extubation of Pediatric Liver Transplant Recipients in the Operating Room. Pediatr Transplant2003, 7 (5), 381–384. https://doi.org/10.1034/j.1399-3046.2003.00072.x.
Arikan, C.; Ozgenç, F.; Akman, S. A.; Yağci, R. V.; Tokat, Y.; Aydoğdu, S. Large-Volume Paracentesis and Liver Transplantation. J Pediatr Gastroenterol Nutr2003, 37 (2), 207–208. https://doi.org/10.1097/00005176-200308000-00025.
Zeytunlu, M.; Icoz, G.; Kiliç, M.; Demirbas, T.; Tokat, Y.; Yuzer, Y. Donor Safety in Adult-to-Adult Living Donor Liver Transplantation. Transplant Proc2003, 35 (4), 1430–1432. https://doi.org/10.1016/s0041-1345-03-00465-2.
Karasu, Z.; Kilic, M.; Cagirgan, S.; Lebe, E.; Yilmaz, F.; Demirbas, T.; Tokat, Y. Hemophagocytic Syndrome after Living-Related Liver Transplantation. Transplant Proc2003, 35 (4), 1482–1484. https://doi.org/10.1016/s0041-1345-03-00511-6.
Icoz, G.; Kilic, M.; Zeytunlu, M.; Celebi, A.; Ersoz, G.; Killi, R.; Memis, A.; Karasu, Z.; Yuzer, Y.; Tokat, Y. Biliary Reconstructions and Complications Encountered in 50 Consecutive Right-Lobe Living Donor Liver Transplantations. Liver Transpl2003, 9 (6), 575–580. https://doi.org/10.1053/jlts.2003.50129.
Icoz, G.; Kilic, M.; Zeytunlu, M.; Yaprak, O.; Arikan, C.; Yuzer, Y.; Tokat, Y. Roux-En-Y Bleeding after Living Donor Liver Transplantation: A Novel Technique for Surgical Treatment. Transplant Proc2003, 35 (4), 1463–1465. https://doi.org/10.1016/s0041-1345-03-00484-6.
Ayanoglu, H. O.; Ulukaya, S.; Tokat, Y. Causes of Postreperfusion Syndrome in Living or Cadaveric Donor Liver Transplantations. Transplant Proc2003, 35 (4), 1442–1444. https://doi.org/10.1016/s0041-1345-03-00483-4.
Zeytunlu, M.; Icoz, G.; Kiliç, M.; Yuzer, Y.; Tokat, Y. Optimal Venous Drainage for Right Lobe Living Donor Liver Grafts. Transplant Proc2002, 34 (8), 3327–3330. https://doi.org/10.1016/s0041-13450203674-6.
Ulukaya, S.; Ayanoglu, H. O.; Acar, L.; Tokat, Y.; Kilic, M. Immediate Tracheal Extubation of the Liver Transplant Recipients in the Operating Room. Transplant Proc2002, 34 (8), 3334–3335. https://doi.org/10.1016/s0041-13450203670-9.
Cavusoglu, C.; Cicek-Saydam, C.; Karasu, Z.; Karaca, Y.; Ozkahya, M.; Toz, H.; Tokat, Y.; Bilgic, A. Mycobacterium Tuberculosis Infection and Laboratory Diagnosis in Solid-Organ Transplant Recipients. Clin Transplant2002, 16 (4), 257–261. https://doi.org/10.1034/j.1399-0012.2002.01098.x.
Tokat, Y.; Yuzer, Y.; Karasu, Z.; Alper, M.; Killi, R.; Zeytunlu, M.; Yilmaz, F. New Frontiers: Adult to Adult Living Donor Liver Transplantation, Single Center Experience from Turkey. Transplant Proc2001, 33 (7–8), 3458–3460. https://doi.org/10.1016/s0041-13450102490-3.
Yağdi, T.; Büket, S.; Tokat, Y.; Posacioglu, H.; Aşkar, F. Circulatory Arrest to Protect Transplant Kidney in a Patient with Chronic Type III Dissection. Ann Vasc Surg2001, 15 (5), 575–577. https://doi.org/10.1007/s10016-001-0008-9.
Sayiner, A.; Ece, T.; Duman, S.; Yildiz, A.; Ozkahya, M.; Kiliçaslan, Z.; Tokat, Y. Tuberculosis in Renal Transplant Recipients. Transplantation1999, 68 (9), 1268–1271. https://doi.org/10.1097/00007890-199911150-00009.
Ok, E.; Unsal, A.; Celik, A.; Zeytinoğlu, A.; Ersöz, G.; Tokat, Y.; Erensoy, S.; Akarca, U. S.; Basçi, A.; Yüce, G. Clinicopathological Features of Rapidly Progressive Hepatitis C Virus Infection in HCV Antibody Negative Renal Transplant Recipients. Nephrol Dial Transplant1998, 13 (12), 3103–3107. https://doi.org/10.1093/ndt/13.12.3103.
Uslu, A.; Tokat, Y.; Ok, E.; Unsal, A.; Celik, A.; Yalaz, S.; Kaplan, H. Impact of Extreme Donor Age on the Outcome of Living-Related Donor Kidney Transplantation. Transplant Proc1998, 30 (3), 734–737. https://doi.org/10.1016/s0041-13459800028-1.
Yararbai, O.; Osmanodlu, H.; Kaplan, H.; Tokat, Y.; Coker, A.; Korkut, M.; Kapkac, M. Esophagocoloplasty in the Management of Postcorrosive Strictures of the Esophagus. Hepatogastroenterology1998, 45 (19), 59–64.
Uslu, A.; Tokat, Y.; Ok, E.; Unsal, A.; Ilkgul, O.; Kaplan, H. ATG versus OKT3 in the Treatment of Steroid-Resistant Rejection Following Living-Related Donor Renal Transplantation. Transplant Proc1997, 29 (7), 2805–2806. https://doi.org/10.1016/s0041-13459700686-6.
Tokat, Y.; Uslu, A.; Ok, E.; Tunçyürek, P.; Celik, A.; Yararbaş, O. Surgical Management of Vesicoureteral Reflux Following Renal Transplantation. Transplant Proc1997, 29 (7), 3073–3074. https://doi.org/10.1016/s0041-13459700787-2.
Kurşat, S.; Ok, E.; Zeytinoglu, A.; Tokat, Y.; Saydam, G.; Cirit, M.; Akçiçek, F. Nocardiosis in Renal Transplant Patients. Nephron1997, 75 (3), 370–371. https://doi.org/10.1159/000189570.
Cagirgan, S.; Cirit, M.; Ok, E.; Sencan, M.; Hekimgil, M.; Unsal, A.; Saydam, G.; Tokat, Y. Castleman’s Disease in a Renal Allograft Recipient. Nephron1997, 76 (3), 352–353. https://doi.org/10.1159/000190204.
Tokat, Y.; Zeytunlu, M.; Kilic, M.; Kaplan, H.; Yararbaş, O. Gastrointestinal Complications in Renal Transplantation. Transplant Proc1996, 28 (4), 2351–2352.
Tokat, Y.; Kiliç, M.; Kürşat, S.; Ok, E.; Sayiner, A.; Tanil, V.; Başçi, A. Tuberculosis after Renal Transplantation. Transplant Proc1996, 28 (4), 2353–2354.
Soin, A. S.; Friend, P. J.; Rasmussen, A.; Saxena, R.; Tokat, Y.; Alexander, G. J.; Jamieson, N. V.; Calne, R. Y. Donor Arterial Variations in Liver Transplantation: Management and Outcome of 527 Consecutive Grafts. Br J Surg1996, 83 (5), 637–641. https://doi.org/10.1002/bjs.1800830515.
Ok, E.; Akcicek, F.; Toz, H.; Coker, A.; Kursat, S.; Tokat, Y.; Arac, N. Goitre and Severe Autonomic Neuropathy Due to Secondary Amyloidosis in a Renal Transplant Patient. Clin Nephrol1996, 45 (5), 361–362.
Ok, E.; Kursat, S.; Tokat, Y.; Cirit, M.; Tombuloglu, M.; Akcicek, F. The Reproducibility of Cyclosporin-Induced Hemolytic Uremic Syndrome in a Renal Allograft Recipient. Nephron1996, 74 (1), 238. https://doi.org/10.1159/000363081.
Ok, E.; Kursat, S.; Alev, M.; Tobu, M.; Tokat, Y.; Akcicek, F.; Hoscoskun, C.; Basci, A. Further Evidence of Favorable Effects of Gemfibrozil on the Lipid Profile in Renal Allograft Recipients. Nephron1996, 73 (3), 491–492. https://doi.org/10.1159/000189121.
Saxena, R.; Tokat, Y.; Rasmussen, A.; Jamieson, N. V.; Calne, R. Segmental Arteries to Segments I-IV from the Common Hepatic Artery. Br J Surg1995, 82 (6), 817–818. https://doi.org/10.1002/bjs.1800820631.
Tokat, Y.; Soin, A.; Saxena, R.; Watson, C. J.; Rasmussen, A.; Sakurada, M.; Wight, D.; Friend, P. J.; Jamieson, N. V.; Calne, R. Y. Posttransplant Problems Requiring Regrafting: An Analysis of 72 Patients with 96 Liver Retransplants. Transplant Proc1995, 27 (1), 1264–1265.
Soin, A. S.; Rasmussen, A.; Jamieson, N. V.; Tokat, Y.; Watson, C. J.; Friend, P. J.; Wight, D. G.; Calne, R. Y. Cyclosporine Levels in the Early Posttransplant Period: Predictive of Chronic Rejection in Liver Transplantation? Transplant Proc1995, 27 (1), 1129–1130.
Saxena, R.; Tokat, Y.; Soin, A. S.; Rasmussen, A.; Jamieson, N. V.; Calne, R. Relationship between Patterns of Hepatobiliary Vascular Supply and Biliary Complications in Liver Transplantation: An Anatomical and Clinical Analysis. Transplant Proc1995, 27 (1), 1199–1200.
Chávez-Cartaya, R.; Rasmussen, A.; Tokat, Y.; Jamieson, N. V. Effect of Preservation Time on Early Graft Function and Outcome of Orthotopic Liver Transplants. Transplant Proc1995, 27 (1), 724–726.
Ok, E.; Akcicek, F.; Coker, A.; Tombuloğlu, M.; Toz, H.; Tokat, Y.; Cirit, M.; Tobu, M.; Onder, G.; Basci, A. Alloimmune Haemolytic Anaemia after Renal Transplantation. Nephrol Dial Transplant1995, 10 (3), 404–405.
Coker, A.; Ok, E.; Tokat, Y.; Hoşcoşkun, C.; Kaplan, H.; Yararbaş, O. Evaluation of Patients Transplanted in Countries Other than Turkey. Transplant Proc1994, 26 (4), 2455–2456.
Tokat, Y.; Coker, A.; Basci, A.; Hoscoskun, C.; Kaplan, H.; Yararbas, O. Is Mezlocilline Prophylaxis Effective in Clinical Renal Transplantation? Transplant Proc1992, 24 (5), 1757.
Karacan, I.; Moore, C. A.; Hirshkowitz, M.; Sahmay, S.; Narter, E. M.; Tokat, Y.; Tuncel, L. Uterine Activity during Sleep. Sleep1986, 9 (3), 393–398. https://doi.org/10.1093/sleep/9.3.393.